Home Blog Page 264

Search Suspended for Two Missing Villagers in Xaysomboun Cave

Xaysomboun Cave Rescue Suspended. (Photo: MTK Command & Control Center)

Rescue teams have suspended operations inside a semi-flooded cave in Xaysomboun after part of the entrance showed signs of collapse, raising serious safety concerns. Two villagers remain missing after flash floods trapped seven men inside the cave on 20 May.

Teams successfully rescued five of the men by 30 May, guided through submerged passages and aided by water pumping operations. The remaining two villagers entered the cave separately and have not been located despite intensive searches. Authorities and international specialists continued managing water flow and monitoring the surrounding terrain to reduce risk and improve conditions for any potential rescue for over 10 days.

The mission faced extreme challenges, including narrow passages, low oxygen levels, rising water, and unstable rock formations. Rescue crews worked under difficult conditions, with vertical clearances reduced to around 30 centimeters in flooded sections on 5 June.

Rescue teams from Laos and Thailand, including foreign divers who took part in Thailand’s 2018 Tham Luang cave rescue, spent days pumping water from the flooded cave and delivering food, medicine and supplies to the five villagers found alive on 29 May.

Efforts were repeatedly hampered by heavy rain, rising water levels and unstable conditions inside the cave. The five men were eventually rescued, but efforts to locate the remaining two villagers continued for another week before being suspended.

Global Rise in Delayed Childbearing and Infertility Drives Demand for Cross-Border Fertility Care

Asian Case Studies Highlight How Regulation, Cost, and Access Are Shaping International Family Choices

TAIPEI, June 6, 2026 /PRNewswire/ — Delayed marriage, postponed childbearing, and infertility continue to draw global attention as more individuals and couples seek reproductive care beyond their home countries. As the average age of parenthood rises, differences in regulations, treatment costs, and access across markets have made cross-border fertility care a highly specialized segment of the international medical landscape.

According to data from more than 2,300 cross-border patient families treated at TFC Taipei Fertility Center, patients aged 35 to 40 represent the largest group, while those over 40 account for nearly 30%, underscoring advanced maternal age and delayed parenthood as major drivers of fertility travel.

For couples facing fertility challenges, selecting a treatment destination involves more than success rates. Clinical experience, laboratory quality, regulatory conditions, pricing transparency, language support, treatment scheduling, and follow-up care all play a role in decision-making.

Taiwan has emerged as a preferred destination for fertility patients from Asia, Europe, and North America, supported by a mature regulatory framework, extensive clinical expertise, high medical standards, and comparatively affordable costs. As a result, the number of international patients seeking fertility care in Taiwan continues to increase each year.

Since its founding in 2020, TFC has supported families from five continents and more than 50 countries and regions. IVF remains the most common treatment, followed by egg freezing, intrauterine insemination, and egg donation. Patients from Japan and France are often affected by domestic regulatory restrictions and advanced maternal age, while patients from Singapore, Malaysia, Hong Kong, and Macau often value cost-effectiveness and efficient treatment planning. Patients from the U.S., U.K., and South Korea frequently seek care for repeated implantation failure or diminished ovarian reserve.

Dr. Chii-Ruey Tzeng, founder of Taipei Fertility Center, said Taiwan’s reproductive medicine expertise, combined with support that helps international patients overcome language and system barriers, enables comprehensive evaluation, personalized treatment, and ongoing follow-up within a limited stay.

By integrating AI-based assessment with precision medicine, TFC has established a one-stop patient management model that includes remote consultation, treatment planning, multilingual communication, and post-treatment follow-up.

About TFC Taipei Fertility Center

a Taiwan-based medical institution specializing in reproductive medicine, embryology, and international healthcare services. It provides infertility evaluation, IVF treatment, egg freezing, fertility preservation, advanced embryology services, and personalized reproductive care.

Asian Case Studies Highlight How Regulation, Cost, and Access Are Shaping International Family Choices - Taiwan has emerged as a preferred destination for fertility patients
Asian Case Studies Highlight How Regulation, Cost, and Access Are Shaping International Family Choices – Taiwan has emerged as a preferred destination for fertility patients

CST Tires Showcases Lightweight Innovation at 2026 China International Bicycle Expo

SHANGHAI, June 6, 2026 /PRNewswire/ — Recently, the highly anticipated 34th China International Bicycle Exhibition (CHINA CYCLE) concluded successfully at the Shanghai New International Expo Center. As one of the largest and most influential events in the global cycling industry, this year’s expo brought together nearly a thousand manufacturers of bicycles and components, serving as a key platform for unveiling new products and sharing industry insights.

As a leading brand in the two-wheeler tire sector, CST Tires presented its award-winning signature products alongside a newly upgraded lineup of green and intelligent solutions. Centered around the 2026 marketing theme “Move with the Scene, Ride Lightweight”, the brand created a dedicated “Disappearing Weight” exhibition area, which quickly became a focal point on the opening day, demonstrating the innovation and strength of Chinese manufacturing.

“Disappearing Weight” Exhibition Zone: Extreme Lightweight Technology

The “Disappearing Weight” zone highlighted CST Tires’s commitment to ultra-lightweight performance, translating technical specifications into a tangible riding experience. Visitors were invited to witness firsthand the brand’s 2026 theme: “The lighter, the faster; the lighter, the steadier.”

Two flagship lightweight products stood out at the exhibition:

  • CST MACHVOLT PRO G5: This high-end road racing tire combines aesthetic design with outstanding performance, earning the 2026 MUSE Design Gold Award in the United States. Its tread features an innovative “fighter jet-inspired” pattern with multi-directional grooves and 3D nano-laser engraving, creating a visually dynamic effect while delivering lightweight durability. A low rolling resistance structure with high-pressure support provides stable grip and responsive handling in both dry and wet conditions. The MACHVOLT PRO G5 also received the “Innovation Award” from the CHINA CYCLE 2026 Innovation Awards jury.

    CST Tires Xiamen Group General Manager, Mr. Xu Zhiming, was invited to accept the award.

  • CST NANOLITE Extreme Inner Tube: True to the “Disappearing Weight” concept, this ultra-thin inner tube measures just 0.45mm, 50% lighter than standard inner tubes, designed for riders seeking extreme weight reduction.

Comprehensive Coverage: From Professional Racing to Urban Commuting

CST Tires showcased its deep expertise across E-BIKE, mountain bike, and urban commuting segments, aligning with trends in large-diameter off-road tires, outdoor adventures, and city “4+2” commuting (car + bike).

Off-Road Innovations: Conquering All Terrains

  • CST C1846 PATROL 32er: The first 32-inch mountain XC tire launched domestically, designed for complex forest terrains and professional off-road riders.
  • CST CMT-16 PRESTON TERRA: An E-MTB tire featuring continuous block tread for low rolling resistance, excellent mud and water drainage, and enhanced cornering stability with DC2 Enduro compound for grip and durability.

Urban Riding Solutions: Practical and Portable
For the growing urban cycling market, CST Tires introduced tires catering to folding bikes for commuting and weekend “4+2” trips:

  • CST CTC-39 ANCLA: Optimized for unpaved surfaces with polygonal central tread and herringbone pattern for stability, directional control, and mud-shedding.
  • CST CTC-36 METRO ALPHA: Designed for paved urban roads with ultra-low rolling resistance and strong grip in dry and wet conditions.

Trend-Driven Design: Defining a New E-BIKE Aesthetic

  • CST CTC-40 BIG BOAT ALPHA: Upgraded from the popular BIG BOAT line, tailored for E-FAT bikes. Incorporates contemporary design elements for both performance and visual appeal in the urban E-BIKE market.

Exhibition Highlights and “Wind Chaser 100” Initiative

The CST Tires booth attracted numerous OEMs, distributors, industry media, and cycling enthusiasts. With its keen market insight and strong product execution, CST reinforced its position as a trendsetter in the tire industry. In conjunction with the “Move with the Scene, Ride Lightweight” theme, the brand launched the “Wind Chaser 100” campaign, inviting 100 cycling ambassadors nationwide to promote lightweight riding concepts and unlock new experiences.

Although the expo has concluded, CST Tires continues to explore lightweight cycling innovations. Industry partners and cycling enthusiasts are encouraged to follow CST Tires for the latest product updates in 2026 and participate in the “Wind Chaser 100” initiative, collectively discovering the limitless potential of two-wheel mobility.

 

Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control

Breakthrough preclinical data demonstrate that LiCO-saUcp1 effectively turns white fat into calorie-burning brown fat, driving massive fat loss while fully preserving lean muscle mass and preventing post-treatment weight rebound.

NEW ORLEANS, June 6, 2026 /PRNewswire/ — Ractigen Therapeutics, a pioneering clinical-stage biotechnology company developing innovative small activating RNA (saRNA) therapeutics, today announced that a late-breaking abstract on LiCO-saUcp1, its first-in-class saRNA candidate for obesity, has been accepted for poster presentation at the American Diabetes Association (ADA) 86th Scientific Sessions, being held June 5–8, 2026, in New Orleans, Louisiana.

While current incretin therapies drive significant weight loss, they are increasingly plagued by the loss of lean muscle mass and rapid weight rebound upon discontinuation. Data to be presented at ADA demonstrate that LiCO-saUcp1 directly solves this industry-wide challenge. Utilizing the company’s proprietary Lipid-Conjugated Oligonucleotide (LiCO™) delivery platform, the therapy uses saRNA to target and upregulate the Ucp1 gene—a powerful driver of metabolic thermogenesis that has historically been considered “undruggable” by conventional pharmaceuticals.

“The obesity market is urgently looking for the ‘next generation’ of therapeutics that go beyond simply suppressing appetite,” said Long-Cheng Li, MD, Founder and Chief Executive Officer of Ractigen Therapeutics. “saRNA opens an entirely new frontier in obesity control. By activating the body’s own thermogenic switch, we are changing the fundamental composition of weight loss. Our data show we can deliver profound fat reduction while protecting a patient’s muscle mass and reprogramming their metabolism to prevent the dreaded post-treatment rebound. This is the definition of high-quality weight loss.”

Key Highlights from the ADA Late-Breaking Presentation:

  • True “High-Quality” Weight Loss: In diet-induced obesity (DIO) models, LiCO-saUcp1 slashed fat mass by 45% while completely preserving lean muscle mass. In a direct comparison, standard-of-care semaglutide caused a detrimental 19% loss in lean mass.
  • Elimination of the Rebound Effect: Animals treated with LiCO-saUcp1 maintained their body weight and sustained a 46% fat mass loss for two full months after the drug was withdrawn, sharply contrasting with the rapid weight regain seen upon semaglutide withdrawal.
  • Best-in-Class Synergy: When combined with semaglutide, LiCO-saUcp1 synergistically drove a remarkable 69% reduction in fat mass (compared to 47% with semaglutide alone), without worsening the muscle depletion typically caused by GLP-1s.
  • Significant Liver Health Benefits: The therapy dose-dependently reduced liver triglycerides by up to 79%, demonstrating deep resolution of hepatic steatosis (fatty liver).

By proving that RNA activation can safely unlock Ucp1-driven thermogenesis, Ractigen Therapeutics is establishing a highly differentiated therapeutic mechanism that can act as a standalone treatment or as the ideal combination partner for existing incretin therapies.

The abstract is available online via the journal Diabetes® website.

Presentation Details at ADA 2026:

  • Title: Activating the Adipose Thermogenic Switch: A First-in-Class Ucp1 saRNA Drives Durable, High-Quality Weight Loss in Diet-Induced Obese Mice
  • Poster Number: 3066-LB
  • Presenter: Moorim Kang, PhD, Chief Technology Officer
  • Date/Time: Sunday, June 7, 2026, 12:30 PM – 1:30 PM
  • Location: Ernest N. Morial Convention Center, New Orleans, LA

About RNAa
RNA activation (RNAa) is a clinically validated platform technology developed by Dr. Long-Cheng Li and his team. It utilizes small activating RNAs (saRNAs) to target gene regulatory domains, robustly activating endogenous gene expression and restoring therapeutic protein levels. This innovative technology holds vast potential for developing disease-modifying therapeutics, particularly against targets where traditional inhibitory methods fall short.

About Ractigen Therapeutics
Ractigen Therapeutics is a clinical-stage biopharmaceutical company innovating next-generation RNA therapeutics, with a primary focus on small activating RNAs (saRNAs) developed through its clinically validated RNA activation (RNAa) technology. Leveraging proprietary delivery platforms such as SCAD™, LiCO™, and GLORY™, Ractigen is advancing a robust pipeline addressing unmet medical needs in oncology, neurological diseases, and genetic disorders. Its versatile technologies also enable the rapid development of RNA-based solutions, including siRNAs, where applicable, to target life-threatening, fast-progressing conditions such as those in the CNS. Committed to scientific excellence and patient-centered innovation, Ractigen strives to transform healthcare through the power of RNA therapeutics. For more information, visit www.ractigen.com.

Sun Group debuts at SITF 2026 with exclusive Phu Quoc flight deals and a fresh vision for Vietnam tourism


SEOUL, SOUTH KOREA – Media OutReach Newswire – 6 June 2026 – Making its first-ever appearance at the Seoul International Travel Fair (SITF) 2026, one of South Korea’s largest international travel fairs, held from June 4–7, Sun Group has delivered a meaningful message: “Visit Vietnam: Beloved Destinations – Extraordinary Experiences.” The group has showcased iconic destinations including Da Nang, Phu Quoc, Sa Pa, and Ha Long, while telling the story of a Vietnam that is constantly innovating to create unique experiences for global travelers.

The Sun Group booth attracts a large number of visitors with its interactive activities, destination ecosystem, and promotions.
The Sun Group booth attracts a large number of visitors with its interactive activities, destination ecosystem, and promotions.

A special highlight is Sun Group’s unveiling of its new development vision for Phu Quoc in the lead‑up to APEC 2027, presented directly to Korean partners and visitors.

From the first day of the fair, Sun Group’s booth has welcomed a steady stream of visitors. Throughout the four-day event, the booth has organized B2B and B2C networking activities, customer consultations, and introductions to tourism, resort, and aviation products. Interactive programs, including mini-games, souvenir giveaways, and tailored offers for the Korean market, have kept the atmosphere lively for hours, with a continuous flow of engaged visitors.

During SITF (June 4–7), travelers have the opportunity to receive a 20% discount on the base fare when booking Sun PhuQuoc Airways tickets via the airline’s website or app. The offer applies to the Korean market for one‑way or round‑trip journeys from Korea to Phu Quoc. Limited to 200 Economy Class discount codes, it is valid for flights from June 15 to October 24, 2026 (excluding peak periods as defined by the airline).

Visitors also have the chance to win attractive prizes through booth activities, including free round‑trip air tickets on the Seoul–Phu Quoc route (ICN–PQC) and resort vouchers at hotels within Sun Group’s ecosystem.

By combining destination promotion with airline incentives, Sun Group aims to further encourage South Korean tourists to choose Vietnam for their upcoming holidays, especially Phu Quoc, which is entering a new era of large‑scale investments in projects, products, and experiences all aimed at APEC 2027.

Hashtag: #SunGroup

The issuer is solely responsible for the content of this announcement.

About Sun Group

Vietnam’s leading private economic group, Sun Group operates an integrated ecosystem spanning tourism, entertainment, hospitality, real estate, infrastructure, and aviation. Guided by the mission “Enhancing the beauty of the lands,” the Group shapes iconic destinations nationwide through its Sun World entertainment brand. In the aviation sector, Sun Group develops a hub-and-spoke model anchored by Phu Quoc, driven by strategic airport investments and Sun PhuQuoc Airways.

Guild Wars 3, Modern Evolution of the MMORPG, Announced at Summer Game Fest for PC and PlayStation 5

The First Time a Game in the Legendary Franchise Comes to Consoles

BELLEVUE, Wash., June 6, 2026 /PRNewswire/ — Critically-acclaimed game development studio ArenaNet® tonight announced Guild Wars 3™, the third entry in the legendary and beloved Guild Wars® MMORPG franchise and their first new game since 2012. The game will release globally on PC, Steam, and PlayStation 5, marking the first time a Guild Wars game will appear on home consoles. The first beta test is scheduled for fall of 2027.

Guild Wars 3 - The land of Orr
Guild Wars 3 – The land of Orr

The official debut trailer features the first in-engine gameplay footage and can be viewed HERE. The first concept art and other assets are hosted at the Guild Wars 3 official press kit.

Guild Wars 3 is a new era not just for ArenaNet and Guild Wars, but also for MMORPGs as a whole,” said Colin Johanson, Guild Wars 3 Game Director and ArenaNet Studio Head. “The MMORPG genre has millions of players worldwide eager for new, modern experiences, and the opportunity to harness that excitement is immense. Our approach with Guild Wars 3 is to push MMORPGs forward, to create an online game world that feels believable, rewarding, responsive, and innovative while at the same time respecting players’ time and providing a positive, supportive space to build community and enjoy new stories in our universe.”

Taking place over a thousand years before the events of the original game, Guild Wars 3 is set in the Tyrian region of Orr, a vast wilderness frontier imbued with the world’s magic. Nature entities with strong connections to the land called Vael spirits embody the vitality of this lush, verdant landscape. Various guilds are engaged in conflict over how to protect or exploit the bounty beyond civilization’s borders. These multitudinous spirits will vary in size and influence within the ecosystems around them, with the most notable of these being the Seeker. As seen in the trailer, every player’s Seeker will serve as a connection to the spirits of Orr and a mount that will carry them on their journeys through the game’s open world.

Players will assume the role of a Vaelwarden, a member of a guild of adventurers committed to preserving and protecting both the spirits of the wild and the land of Orr itself. Through the deep character customization and skill-building gameplay the Guild Wars franchise is known for, players will seek adventure and confront danger across this sumptuous, vibrant online world, growing their relationships with the spirits of the wild, the inhabitants of Orr, and other Vaelwarden players.

A combat system designed from the outset to feel great on both a controller and keyboard rewards positioning by emphasizing the joy of movement and momentum. As players seamlessly transition between various movement modes, they can harness their speed and turn it into bigger damage and impact when fighting their foes.  

More information about pricing, beta tests, release date, and gameplay features will be revealed later in 2026 and into 2027. Guild Wars 3 will be available directly from the developers at GuildWars3.com, and can be wishlisted on Steam and the PlayStation Store beginning today, with more information available at the game’s official website.

About the Guild Wars Franchise
Guild Wars is the award-winning, visually stunning MMORPG franchise that originally launched in 2005 on PC. Boasting a timeless art-brought-to-life aesthetic, the epic grandeur of massive role-playing environments, fast-paced action combat, large-scale dynamic events that players tackle together in the open world, team-based competitive player-versus-player battles, and a sprawling fantasy storyline, the series is often proclaimed as having the friendliest player community in gaming. Guild Wars was relaunched as Guild Wars Reforged in 2025 and expanded to mobile devices in 2026. Guild Wars 2® launched in 2012 on PC and quickly earned accolades across the industry, including Time Magazine’s 2012 Game of the Year. Unlike most competitors, the franchise has always been playable with no subscription fee required, welcoming over 29 million players across its history.

About ArenaNet
ArenaNet is the developer of the best-selling Guild Wars Reforged and the groundbreaking Guild Wars 2 massively multiplayer online PC role-playing games. The studio’s mission is to create innovative online worlds, cultivate a vibrant and engaged global community of players, and to incorporate handcrafted artistry into every aspect of their games. ArenaNet formed in 2000, with press and fans consistently calling Guild Wars and Guild Wars 2 two of the best MMOs and RPGs of all time. Based in Bellevue, WA, ArenaNet is a wholly-owned subsidiary of Korean gaming giant NC.

Quantinuum Announces Closing of Upsized Initial Public Offering

BROOMFIELD, Colo., June 6, 2026 /PRNewswire/ — Quantinuum Inc. (Nasdaq: QNT) (“Quantinuum”) today announced the closing of its upsized initial public offering of 28,000,000 shares of its Class A common stock at an initial public offering price of $60.00 per share. All of the shares were offered by Quantinuum. The aggregate gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses were $1.68 billion. Quantinuum’s Class A common stock is listed on the Nasdaq Global Market under the ticker symbol “QNT.”

J.P. Morgan and Morgan Stanley (in alphabetical order) acted as joint lead active book-running managers for the offering; Jefferies and Evercore ISI also acted as active book-running managers; BofA Securities, UBS Investment Bank, Cantor, Mizuho, Needham & Company, Societe Generale and TD Cowen acted as joint-book running managers; and Craig-Hallum and Rosenblatt acted as co-managers for the offering.

A registration statement relating to this offering was declared effective by the Securities and Exchange Commission (the “SEC”) on June 3, 2026. A prospectus relating to and describing the terms of the offering has been filed with the SEC and is available on the SEC’s website at www.sec.gov. The offering is being made available only by means of a prospectus. Copies of the prospectus may be obtained from: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717 or by email at prospectus-eq_fi@jpmchase.com and postsalemanualrequests@broadridge.com; Morgan Stanley & Co. LLC, 180 Varick Street, 2nd Floor, New York, New York 10014, Attention: Prospectus Department or by email at prospectus@morganstanley.com; Jefferies LLC, Attn: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, New York 10022, by telephone at (877) 821-7388 or by email at Prospectus_Department@Jefferies.com; or Evercore Group L.L.C., Attention: Equity Capital Markets, 55 East 52nd Street, 35th Floor, New York, New York 10055, by telephone at 888-474-0200 or by email at ecm.prospectus@evercore.com.

This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Quantinuum

Quantinuum is a leading quantum computing company offering a full-stack platform designed to make quantum computing deployable in real-world environments. The company has commercially deployed multiple generations of quantum systems built on the well-established QCCD architecture, which it has implemented with novel designs and capabilities to achieve the industry’s highest accuracy levels based on average two-qubit gate fidelity as of December 31, 2025. Quantinuum has active engagements with market leaders across pharmaceuticals, material science, financial services, and government and industrial markets. Quantinuum’s headquarters is in Broomfield, Colorado, with additional facilities across the United States, United Kingdom, Germany, Japan, Qatar and Singapore.

World-oriented Intelligent Solutions from Tianjin: Bringing Cutting-Edge Technologies into Daily Life

TIANJIN, China, June 6, 2026 /PRNewswire/ — On May 28, 2026, the World Intelligence Expo 2026 opened at the National Convention & Exhibition Center (Tianjin). “Translation & Communication of China” invited two international guests to visit the expo, exploring Tianjin’s intelligent technology innovations from a global perspective and presenting to the world the accelerating pace and evolving landscape of China’s urban intelligent transformation.


7-hour Extreme Smart Tech Hunt in Tianjin

Themed “Intelligence: Extensive Development Space, Sustainable Growth Driver,” the expo brought together more than 700 enterprises to showcase their latest achievements in intelligent technology. Tianjin’s local industries offered numerous highlights. WYBOTICS showcased its swimming pool cleaning robot, designed specifically for home use. Galileo (Tianjin) Technology exhibited a range of four-legged robotic dogs that attracted significant attention for their customizable configurations for firefighting, rescue operations, public security, and other applications.

From industrial inspections to household cleaning, from low-altitude transportation to smart eldercare, a growing number of “Made in Tianjin” intelligent solutions are moving beyond exhibition halls and into real-world use.